A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis‐associated cancer

Abstract

SummaryInterleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) signals play key roles in the pathogenesis of inflammatory bowel disease (IBD). We previously described that both intact cells and a cell wall-derived polysaccharide-peptidoglycan complex (PSPG) in a strain of lactobacillus [Lactobacillus casei Shirota (LcS)] inhibited IL-6 production in lipopolysaccharide (LPS)-stimulated lamina propria mononuclear cells (LPMCs) isolated from murine IBD. Diets with LcS improve murine IBD by suppression of IL-6 synthesis in LPMCs. Moreover, LcS supplementation with fermented milk ameliorates disease activity in patients with active ulcerative colitis. Here, we focused on the specific roles of PSPG in LcS concerning their anti-inflammatory actions. PSPG derived from LcS, and no other strain of lactobacilli, inhibited IL-6 production in LPS-stimulated murine IBD LPMCs. Purified PSPG-I from LcS inhibited IL-6 synthesis in LPS-stimulated murine IBD LPMCs through the inhibition of nuclear factor-jB. The anti-IL-6 action of LcS PSPG was abrogated by masking with monoclonal anti-PSPG-I. Furthermore, PSPG-I-negative L. casei strains (PSPG-I-negative mutant LcS: LC DPSPG-I , L. casei ATCC 334) did not inhibit IL-6 production. Finally, we confirmed the effects of PSPG-I on LcS in the models of both IBD and colitis-associated cancer (CAC). In the IBD model, ingestion of LcS improved ileitis and inhibited activation of IL-6/STAT3 signaling, while ingestion of the LC DPSPG-I strain did not. In the CAC model, treatment with LcS, but not the LC DPSPG-Istrain, showed tumour-suppressive effects with an inhibition of IL-6 production in the colonic mucosa. These results suggested that a specific polysaccharide component in an L. casei strain plays a crucial role in its anti-inflammatory actions in chronic intestinal inflammatory disorders.Keywords: colitis-associated cancer; inflammatory bowel disease; interleukin-6; Lactobacillus; polysaccharide-peptidoglycan complexPlease cite this article in press as: Matsumoto S. et al. A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer, Immunology (2009)

Perceived Changes in Well-Being Following Polysaccharide Intake in Middle-Aged Adults

“…These themes are consistent with previous research of polysaccharide effects. For example, the reports of perceived change in gastrointestinal health are consistent with mechanistic studies in animals that demonstrate positive effects of polysaccharide intake on gut function (Marzorati, et al, 2010;Matsumoto, et al, 2008). Similarly, the reports of perceived improvement in the experience of arthritic pain lend support to the findings of saccharide involvement in arthritic conditions (A.…”

Lectin Microarray Reveals Binding Profiles of Lactobacillus casei Strains in a Comprehensive Analysis of Bacterial Cell Wall Polysaccharides

“…While the bacterium is known to be a strong Th1-type cytokine inducer (32), of which the active component was proposed to be LTA (12), it exerts anti-inflammatory activity against diabetes mellitus (26) and inflammatory bowel disease (24,25) in animal models. It was shown that the cell wall preparation containing PS and PG could be the active component of the anti-inflammatory activity (25). We have focused on the role of cell wall PSs in the immune modulation activities of YIT 9029 and have found that high-molecular-mass cell wall PSs (PS-1) are a prerequisite for anti-inflammatory activity (43).…”

Helminth Infections and Gut Microbiota: The Futuristic Study of Pathogen Virulence and Gut Ecosystem

“…Based on these properties of the Lactobacillaceae group, Glendinning et al [26] hypothesized the existence of a symbiotic relationship between the helminths and the microbes to be one of the key players in reducing intestinal inflammation. Matsumoto et al [27] has also documented the anti-inflammatory properties of some members of the genus Lactobacillus. The exact effects on the gut microbiota as a result of this cascade of reaction have not been investigated in details [5].…”